And Pluvy et al. [67] reported a case of using nivolumab (a PD-1 blocking antibody) combined with sirolimus for treating metastatic lung adenocarcinoma in a patient with sporadic LAM. The gene discussed is RPL17; the disease is lymphangioleiomyomatosis.